| Thursday, March 14th, 2024 |
|
| 13:00 – 17:00 | REG Working Group Research Ideas Brainstorming |
| Friday, March 15th, 2024 | |
| 08:50 – 09:00 | Welcome Prof. G. Walter Canonica |
| 09:00 – 09:55 | Vaccines Session Chair: Dr. Dermot Ryan Epidemiologic perspective of vaccination in respiratory diseases Dr. Joan Soriano Vaccinations & the respiratory patient – Recommendations vs real world use Dr. Alan Kaplan |
| 09:55 – 10:30 | ILD/IPF Session Chair: Dr. Pilar Rivera Ortega Update on emerging drugs for the treatment of idiopathic pulmonary fibrosis: A look towards 2023 and beyond Prof. Luca Richeldi Q & A |
| 10:30 – 11:00 | Coffee Break |
| 11:00 – 12:30 | Asthma Session Chair: Prof. Arnaud Bourdin Mild asthma, update on anti-inflammatory reliever Prof. Alberto Papi When to institute triple therapy – Should all patients go through triple therapy and azithromycin before biologics? Prof. Michael Wechsler |
| 12:30 – 13:30 | Lunch Break |
| 13:30 – 14:30 | COPD Session
Chair: Prof. Therese Lapperre New definitions of exacerbation of COPD: Are they ready for clinical practice? Prof. Marc Miravitlles What's next after triple therapy in COPD? Prof. David Halpin Q & A |
| 14:30 – 15:15 | Rhinitis Session Chair: Dr. Ignacio Ansotegui Novel therapies in rhinitis Dr. Ignacio Ansotegui Rhinitis & asthma – what does the RWE tell us? Prof. Philippe Gevaert AIT & Biologics: a new opportunity of combination treatment Prof. G. Walter Canonica Q & A |
| 15:15 – 15:45 | Coffee Break |
| In the Respiratory hot seat: | |
| 15:45 – 16:30 | PRO/CON
Remission in severe asthma is attainable in most patients Chair: Prof. Celeste Porsbjerg PRO: Prof. Michael Wechsler CON: Dr. Alan Kaplan |
| 16:30 – 17:15 | PRO/CON
DPIs are the devices of choice in COPD or asthma Chair: Prof. Job Van Boven PRO: Prof. Federico Lavorini CON: Jane Scullion |
| Saturday, March 16th, 2024 |
|
| 09:00 – 09:45 |
Cough session
Chair: Dr. Alan Kaplan Specific cough-targeting drugs: past, present, and future Prof. Surinder Birring Q & A |
| 09:45 – 10:30 | Mild – Moderate disease management session
Chair: Prof. Nikos Papadopoulos Identifying which patients progress to severe asthma – new evidence from MANI registry Prof. Fulvio Braido Disease modifying drugs in asthma Prof. Christian Virchow |
| 10:30 – 11:00 | Coffee Break |
| 11:00 – 12:15 | ISAR SESSION Improving the patient journey in severe asthma- lessons from ISAR and future research Chair: Prof. David Price & Dr. Eileen Wang Why is quality improvement needed (patient and specialist perspectives) Prof. Celeste Porsbjerg What has ISAR achieved to date in improving severe asthma care globally (standardized data collection) Prof. Chin Kook Rhee What remains to be achieved by ISAR (practice change goals based on prior research) Dr. Celine Bergeron What are the future research needs for ISAR as a network? Prof. Matthew Peters |
| 12:15 – 13:00 | Keynote
What Registries have taught us in the last decade. Chair: Prof. Sinthia Bosnic – Anticevich Panel: Prof. David Price Prof. Nicolas Roche Prof. Fulvio Braido Prof. Chin Kook Rhee |
| 13:00 | Meeting Close |
Visit the official website of the
Respiratory Effectiveness Group!
Supported by:
Key dates & Deadlines
| Early Registration Deadline: |
December 30th, 2023 |
| Extended Abstract Submission Deadline: |
January 31st, 2024 |
| Notification of Abstracts Acceptance: | February 5th, 2024 |
| REG SUMMIT 2024: | March 14-16, 2024 |
| Security Warning: Please be aware of fraudulent websites or emails being presented as coming from the official conference organiser or official housing office. read more |
